S&P 500   3,750.77 (-2.57%)
DOW   30,303.17 (-2.05%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
S&P 500   3,750.77 (-2.57%)
DOW   30,303.17 (-2.05%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
S&P 500   3,750.77 (-2.57%)
DOW   30,303.17 (-2.05%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
S&P 500   3,750.77 (-2.57%)
DOW   30,303.17 (-2.05%)
QQQ   319.43 (-2.79%)
AAPL   142.06 (-0.77%)
MSFT   232.90 (+0.25%)
FB   272.14 (-3.51%)
GOOGL   1,818.94 (-4.67%)
AMZN   3,232.58 (-2.81%)
TSLA   864.16 (-2.14%)
NVDA   516.71 (-3.85%)
BABA   260.25 (-2.13%)
CGC   37.83 (+6.50%)
GE   11.38 (+0.80%)
MU   75.09 (-5.56%)
AMD   88.84 (-6.20%)
NIO   57.15 (-5.24%)
T   29.14 (-2.05%)
F   10.79 (-3.57%)
ACB   11.20 (+4.97%)
BA   194.03 (-3.97%)
DIS   163.03 (-3.85%)
NFLX   523.28 (-6.88%)
GILD   65.48 (-1.83%)
Log in
OTCMKTS:SBMFF

Sino Biopharmaceutical Stock Forecast, Price & News

$0.96
-0.01 (-0.52 %)
(As of 01/27/2021 02:56 PM ET)
Add
Compare
Today's Range
$0.96
Now: $0.96
$1.00
50-Day Range
$0.85
MA: $0.96
$1.03
52-Week Range
$0.79
Now: $0.96
$1.92
Volume10,800 shs
Average Volume5,055 shs
Market Capitalization$18.03 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.57
Sino Biopharmaceutical Limited, together with its subsidiaries, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. The company operates in three segments: Chinese Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; oncology medicines comprising Saiweijian injections, Yinishu tablets, Shoufu tablets, Anxian capsules, and Qianping injections; cardio-cerebral medicines, including Yilunping tablets, Tuotuo tablets, and Kaina tablets; and orthopedic medicines, such as Gaisanchun capsules and Yigu injections. The company's principal products also comprise digestive system medicines that consist of Aisuping injections, Getai tablets, and Deyou granules; anti-infectious medicines that include Tiance injections, Tianjie injections, and Tianli injections; respiratory system medicines, such as Tianqingsule inhalation powder; and others comprising Debaian cataplasms. In addition, it engages in property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management consultancy services; and outpatient and surgical procedure. Further, the company manufactures, sells, and distributes health food; and develops medical technology. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
Sino Biopharmaceutical logo

MarketRank

Overall MarketRank

0.82 out of 5 stars

Medical Sector

1105th out of 1,926 stocks

Private Households Industry

197th out of 378 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SBMFF
Previous SymbolNASDAQ:SBMFF
CUSIPN/A
CIKN/A
Phone852-2802-9886
Employees23,475
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.51 billion
Cash Flow$0.05 per share
Book Value$0.31 per share

Profitability

Miscellaneous

Outstanding Shares18,882,450,000
Market Cap$18.03 billion
Next Earnings DateN/A
OptionableNot Optionable
$0.96
-0.01 (-0.52 %)
(As of 01/27/2021 02:56 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SBMFF News and Ratings via Email

Sign-up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sino Biopharmaceutical (OTCMKTS:SBMFF) Frequently Asked Questions

How has Sino Biopharmaceutical's stock been impacted by Coronavirus (COVID-19)?

Sino Biopharmaceutical's stock was trading at $1.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SBMFF shares have decreased by 33.7% and is now trading at $0.9550.
View which stocks have been most impacted by COVID-19
.

Is Sino Biopharmaceutical a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sino Biopharmaceutical in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sino Biopharmaceutical stock.
View analyst ratings for Sino Biopharmaceutical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sino Biopharmaceutical?

Wall Street analysts have given Sino Biopharmaceutical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sino Biopharmaceutical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sino Biopharmaceutical?

Sino Biopharmaceutical saw a decrease in short interest during the month of December. As of December 31st, there was short interest totaling 16,368,400 shares, a decrease of 18.0% from the December 15th total of 19,966,000 shares. Based on an average trading volume of 60,400 shares, the short-interest ratio is presently 271.0 days.
View Sino Biopharmaceutical's Short Interest
.

Who are some of Sino Biopharmaceutical's key competitors?

Who are Sino Biopharmaceutical's key executives?

Sino Biopharmaceutical's management team includes the following people:
  • Mr. Ping Tse, Founder & Sr. Vice Chairman (Age 68)
  • Ms. Cheung Ling Cheng, Exec. Vice Chairwoman of the Board (Age 56)
  • Ms. Mingqin Li, VP & Exec. Director (Age 61)
  • Mr. Zhoushan Tian, Exec. Director (Age 56)
  • Mr. Hsin Tse, VP & Exec. Director (Age 50)
  • Mr. Eric S. Y. Tse, Exec. Director (Age 24)
  • Ms. Y. Y. Tse, Exec. Chairman (Age 28)
  • Mr. Yi Li, CEO & Exec. Director (Age 58)
  • Ms. Jiayin Jennie Ma, Group Chief Financial Officer (Age 44)
  • Ms. Fai Chia, VP & Assistant to the Founding Chairman (Age 62)

What is Sino Biopharmaceutical's stock symbol?

Sino Biopharmaceutical trades on the OTCMKTS under the ticker symbol "SBMFF."

How do I buy shares of Sino Biopharmaceutical?

Shares of SBMFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sino Biopharmaceutical's stock price today?

One share of SBMFF stock can currently be purchased for approximately $0.96.

How big of a company is Sino Biopharmaceutical?

Sino Biopharmaceutical has a market capitalization of $18.03 billion and generates $3.51 billion in revenue each year. Sino Biopharmaceutical employs 23,475 workers across the globe.

What is Sino Biopharmaceutical's official website?

The official website for Sino Biopharmaceutical is www.sinobiopharm.com.

How can I contact Sino Biopharmaceutical?

Sino Biopharmaceutical's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The company can be reached via phone at 852-2802-9886 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.